Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hartikka

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The European Journal of Neuroscience|December 1, 1995
Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivoP Hulley, J Hartikka, S Abdel'Al, et al.
Vaccine|June 8, 2001
Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunizationL Reyes, J Hartikka, V Bozoukova, et al.
Vaccine|March 3, 2001
Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigensJ Hartikka, V Bozoukova, M Ferrari, et al.
Human Gene Therapy|June 20, 1996
An improved plasmid DNA expression vector for direct injection into skeletal muscleJ Hartikka, M Sawdey, F Cornefert-Jensen, et al.
Gene Therapy|August 3, 2000
Sodium phosphate enhances plasmid DNA expression in vivoJ Hartikka, V Bozoukova, D Jones, et al.
Gene Therapy|July 5, 2001
Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccineS E Parker, D Monteith, H Horton, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lungC J Wheeler, P L Felgner, Y J Tsai, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The European Journal of Neuroscience|December 1, 1995
Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivoP Hulley, J Hartikka, S Abdel'Al, et al.
Vaccine|June 8, 2001
Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunizationL Reyes, J Hartikka, V Bozoukova, et al.
Vaccine|March 3, 2001
Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigensJ Hartikka, V Bozoukova, M Ferrari, et al.
Human Gene Therapy|June 20, 1996
An improved plasmid DNA expression vector for direct injection into skeletal muscleJ Hartikka, M Sawdey, F Cornefert-Jensen, et al.
Gene Therapy|August 3, 2000
Sodium phosphate enhances plasmid DNA expression in vivoJ Hartikka, V Bozoukova, D Jones, et al.
Gene Therapy|July 5, 2001
Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccineS E Parker, D Monteith, H Horton, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lungC J Wheeler, P L Felgner, Y J Tsai, et al.
Pageof 3